The importance of pre-treatment haemoglobin level in inoperable non-small cell lung carcinoma treated with radical radiotherapy.

H. Langendijk, J. de Jong, R Wanders, P Lambin, B.J. Slotman

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Background and purpose: The purpose of this study was to evaluate the prognostic significance of the pre-treatment haemoglobin level among patients with inoperable non-small cell lung carcinoma (NSCLC) treated with definitive radiotherapy with regard to loco-regional tumour control (LC) and overall survival (OS). Material and methods: Patients (n=526) with previously untreated NSCLC, stages I-IIIb, WHO-performance status of 0-2 were eligible. All patients were treated with definitive external irradiation (60 Gy in 6 weeks). Results: In the multivariate analysis, the pre-treatment haemoglobin level was an independent prognostic factor for both loco-regional control and the overall survival. Conclusions: pre-treatment haemoglobin levels are strongly associated with loco-regional tumour control and the overall survival. © 2003 Elsevier Science Ireland Ltd. All rights reserved.
Original languageEnglish
Pages (from-to)321-5
JournalRadiotherapy and Oncology
Volume67
Issue number3
Early online date1 Jun 2003
DOIs
Publication statusPublished - 2003

Fingerprint

Dive into the research topics of 'The importance of pre-treatment haemoglobin level in inoperable non-small cell lung carcinoma treated with radical radiotherapy.'. Together they form a unique fingerprint.

Cite this